Neonatal Abstinence Syndrome/Fetal Alcohol Syndrome

Substance use and alcohol abuse during pregnancy are significant public health concerns. Neonatal abstinence syndrome (NAS) is a withdrawal syndrome that infants exposed to opioids may experience in the first few days of life. For most infants with NAS, exposure to opioids occurs during pregnancy while they are fetuses. Similarly, prenatal alcohol exposure (PAE) is the most common preventable cause of intellectual and developmental delay and disabilities in the United States. Fetal alcohol spectrum disorders (FASDs) is a term used to describe preventable birth defects and intellectual/developmental disabilities resulting from PAE. This course offers a general overview of NAS assessment, management, and treatment considerations, as well as a brief overview of FASD.

Learning Objectives

After completing this course, participants will be able to:

  • Identify risk factors and clinical signs and symptoms of NAS & FAS
  • Identify systems of care needed for effective coordination of services for parents/caregivers and their children
  • Review effectiveness of methods associated with screening, assessment, and interventions
  • Identify potential barriers to success and strategies to address them
  • Consider staff development needs

Available Continuing Education:  5.5 hours

  • CHES (Certified Heath Education Specialist)
  • CPH-Certified Public Health
  • DMH- Addiction Therapist
  • DMH – Licensed Administrator¬†
  • DMH-Intellectual and Developmental Disabilities Therapist
  • DMH-Mental Health Therapist
  • DMH-Community Support Specialist
  • MAAP-Mississippi Association of Addiction Professionals
  • NAADAC
  • NBCC- National Board of Certified Counselors
  • SW-Social Work

Presenter

Dr. Susan Buttross, MD & Dr. Lauren Tucker, MD

Location

MSPHI

Date

Aug. 28, 2019

Time

9:00 am - 4:00 pm

Presenter

Dr. Susan Buttross, MD & Dr. Lauren Tucker, MD

Location

MSPHI